Related Experiment Video
Updated: Jun 23, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Treatment strategies for acute pulmonary embolism
Marc Blondon1, Henri Bounameaux, Marc Righini
1Division of General Internal Medicine, Department of Internal Medicine, Geneva University Hospital and Faculty of Medicine, 24 rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland. marc.blondon@hcuge.ch
Background:
Acute pulmonary embolism (PE) is a life-threatening condition that has been treated with anticoagulation for almost 50 years.
Objectives:
To review the current treatment options for PE and discuss recently published new features.
Methods:
We reviewed literature involving the treatment strategies for venous thromboembolism (VTE) and in particular pulmonary embolism. Specific attention was drawn towards the evidence of the present treatment and of drugs being studied in Phase III trials.
Results/Conclusions:
Treatment of acute PE consists of parenteral administration of heparin, low-molecular-weight heparin or fondaparinux overlapped and followed by oral vitamin K antagonists for a minimum of 3 months. Contemporary features include the emergence of new anticoagulant drugs such as oral synthetic inhibitors of thrombin or factor Xa. The duration of anticoagulation for unprovoked VTE remains highly debated.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
